Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions |
Total |
Series A Preferred Stock |
Series B Preferred Stock |
Preferred Stock Issued and Outstanding |
Common Stock Issued and Outstanding |
Common Stock Issued and Outstanding
Series A Preferred Stock
|
Common Stock Issued and Outstanding
Series B Preferred Stock
|
Additional Paid-In Capital |
(Accumulated Deficit) Retained Earnings |
Accumulated Other Comprehensive Loss |
| Preferred stock, beginning balance (in shares) at Dec. 31, 2022 |
|
|
|
4,000,000
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2022 |
$ 2,127
|
|
|
$ 0
|
$ 0
|
|
|
$ 2,558
|
$ (164)
|
$ (267)
|
| Common stock, beginning balance (in shares) at Dec. 31, 2022 |
|
|
|
|
233,403,912
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
| Net income |
26
|
|
|
|
|
|
|
|
26
|
|
| Fair value change - derivatives |
(9)
|
|
|
|
|
|
|
|
|
(9)
|
| Foreign currency translation adjustment |
14
|
|
|
|
|
|
|
|
|
14
|
| Gain on dedesignated derivatives amortized from AOCI into income |
(4)
|
|
|
|
|
|
|
|
|
(4)
|
| Preferred Stock dividend (in shares) |
|
|
|
|
|
|
1,082,877
|
|
|
|
| Share repurchases (in shares) |
|
|
|
|
(541,316)
|
|
|
|
|
|
| Share repurchases |
(12)
|
|
|
|
|
|
|
(12)
|
|
|
| Profit sharing plan contributions (in shares) |
|
|
|
|
631,194
|
|
|
|
|
|
| Profit sharing plan contributions |
14
|
|
|
|
|
|
|
14
|
|
|
| Share-based compensation and other, net (in shares) |
|
|
|
|
636,233
|
|
|
|
|
|
| Share-based compensation and other, net |
9
|
|
|
|
|
|
|
9
|
|
|
| Preferred stock, ending balance (in shares) at Mar. 31, 2023 |
|
|
|
4,000,000
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2023 |
2,165
|
|
|
$ 0
|
$ 0
|
|
|
2,569
|
(138)
|
(266)
|
| Common stock, ending balance (in shares) at Mar. 31, 2023 |
|
|
|
|
235,212,900
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Dec. 31, 2022 |
|
|
|
4,000,000
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2022 |
2,127
|
|
|
$ 0
|
$ 0
|
|
|
2,558
|
(164)
|
(267)
|
| Common stock, beginning balance (in shares) at Dec. 31, 2022 |
|
|
|
|
233,403,912
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
| Net income |
74
|
|
|
|
|
|
|
|
|
|
| Fair value change - derivatives |
6
|
|
|
|
|
|
|
|
|
|
| Foreign currency translation adjustment |
41
|
|
|
|
|
|
|
|
|
|
| Preferred Stock dividend (in shares) |
|
|
935,285
|
|
|
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Jun. 30, 2023 |
|
|
|
4,000,000
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2023 |
2,247
|
|
|
$ 0
|
$ 0
|
|
|
2,565
|
(90)
|
(228)
|
| Common stock, ending balance (in shares) at Jun. 30, 2023 |
|
|
|
|
235,270,405
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Mar. 31, 2023 |
|
|
|
4,000,000
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2023 |
2,165
|
|
|
$ 0
|
$ 0
|
|
|
2,569
|
(138)
|
(266)
|
| Common stock, beginning balance (in shares) at Mar. 31, 2023 |
|
|
|
|
235,212,900
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
| Net income |
48
|
|
|
|
|
|
|
|
48
|
|
| Fair value change - derivatives |
15
|
|
|
|
|
|
|
|
|
15
|
| Foreign currency translation adjustment |
27
|
|
|
|
|
|
|
|
|
27
|
| Gain on dedesignated derivatives amortized from AOCI into income |
(4)
|
|
|
|
|
|
|
|
|
(4)
|
| Preferred Stock dividend (in shares) |
|
|
436,992
|
|
|
|
436,992
|
|
|
|
| Share repurchases (in shares) |
|
|
|
|
(428,688)
|
|
|
|
|
|
| Share repurchases |
(11)
|
|
|
|
|
|
|
(11)
|
|
|
| Share-based compensation and other, net (in shares) |
|
|
|
|
49,201
|
|
|
|
|
|
| Share-based compensation and other, net |
7
|
|
|
|
|
|
|
7
|
|
|
| Preferred stock, ending balance (in shares) at Jun. 30, 2023 |
|
|
|
4,000,000
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2023 |
2,247
|
|
|
$ 0
|
$ 0
|
|
|
2,565
|
(90)
|
(228)
|
| Common stock, ending balance (in shares) at Jun. 30, 2023 |
|
|
|
|
235,270,405
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Dec. 31, 2023 |
|
4,000,000
|
800,000
|
4,000,000
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
2,071
|
|
|
$ 0
|
$ 0
|
|
|
2,572
|
(11)
|
(490)
|
| Common stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
|
235,575,316
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
| Net income |
45
|
|
|
|
|
|
|
|
45
|
|
| Fair value change - derivatives |
13
|
|
|
|
|
|
|
|
|
13
|
| Foreign currency translation adjustment |
(42)
|
|
|
|
|
|
|
|
|
(42)
|
| Gain on dedesignated derivatives amortized from AOCI into income |
(4)
|
|
|
|
|
|
|
|
|
(4)
|
| Preferred Stock dividend (in shares) |
|
|
|
|
|
7,944,104
|
620,240
|
|
|
|
| Series B Preferred Stock dividend |
0
|
|
|
|
|
|
|
7
|
(7)
|
|
| Conversion of Series B Preferred Stock, net (in shares) |
|
|
|
|
16,260,163
|
|
|
|
|
|
| Conversion of Series B Preferred Stock, net |
197
|
|
|
|
|
|
|
214
|
(17)
|
|
| Profit sharing plan contributions (in shares) |
|
|
|
|
510,319
|
|
|
|
|
|
| Profit sharing plan contributions |
18
|
|
|
|
|
|
|
18
|
|
|
| Share-based compensation and other, net (in shares) |
|
|
|
|
726,809
|
|
|
|
|
|
| Share-based compensation and other, net |
3
|
|
|
|
|
|
|
3
|
|
|
| Preferred stock, ending balance (in shares) at Mar. 31, 2024 |
|
|
|
4,000,000
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2024 |
2,301
|
|
|
$ 0
|
$ 0
|
|
|
2,814
|
10
|
(523)
|
| Common stock, ending balance (in shares) at Mar. 31, 2024 |
|
|
|
|
261,636,951
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Dec. 31, 2023 |
|
4,000,000
|
800,000
|
4,000,000
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
2,071
|
|
|
$ 0
|
$ 0
|
|
|
2,572
|
(11)
|
(490)
|
| Common stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
|
235,575,316
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
| Net income |
114
|
|
|
|
|
|
|
|
|
|
| Fair value change - derivatives |
17
|
|
|
|
|
|
|
|
|
|
| Foreign currency translation adjustment |
(43)
|
|
|
|
|
|
|
|
|
|
| Preferred Stock dividend (in shares) |
|
|
283,196
|
|
|
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Jun. 30, 2024 |
|
4,000,000
|
0
|
4,000,000
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2024 |
2,835
|
|
|
$ 0
|
$ 0
|
|
|
3,280
|
79
|
(524)
|
| Common stock, ending balance (in shares) at Jun. 30, 2024 |
|
|
|
|
274,319,653
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Mar. 31, 2024 |
|
|
|
4,000,000
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2024 |
2,301
|
|
|
$ 0
|
$ 0
|
|
|
2,814
|
10
|
(523)
|
| Common stock, beginning balance (in shares) at Mar. 31, 2024 |
|
|
|
|
261,636,951
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
| Net income |
69
|
|
|
|
|
|
|
|
69
|
|
| Fair value change - derivatives |
4
|
|
|
|
|
|
|
|
|
4
|
| Foreign currency translation adjustment |
(1)
|
|
|
|
|
|
|
|
|
(1)
|
| Gain on dedesignated derivatives amortized from AOCI into income |
(4)
|
|
|
|
|
|
|
|
|
(4)
|
| Issuance of common shares (in shares) |
|
|
|
|
12,650,000
|
|
|
|
|
|
| Issuance of common shares |
458
|
|
|
|
|
|
|
458
|
|
|
| Share-based compensation and other, net (in shares) |
|
|
|
|
32,702
|
|
|
|
|
|
| Share-based compensation and other, net |
8
|
|
|
|
|
|
|
8
|
|
|
| Preferred stock, ending balance (in shares) at Jun. 30, 2024 |
|
4,000,000
|
0
|
4,000,000
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2024 |
$ 2,835
|
|
|
$ 0
|
$ 0
|
|
|
$ 3,280
|
$ 79
|
$ (524)
|
| Common stock, ending balance (in shares) at Jun. 30, 2024 |
|
|
|
|
274,319,653
|
|
|
|
|
|